Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BCEL | C | Atreca, Inc. | 0.00 | |
IMNM | C | Immunome, Inc. | -2.21 | |
ADAP | C | Adaptimmune Therapeutics plc | -4.51 | |
CKPT | C | Checkpoint Therapeutics, Inc. | -3.35 | |
MRKR | C | Marker Therapeutics, Inc. | -1.02 | |
ZYME | C | Zymeworks Inc. | -3.35 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | -2.48 | |
TIL | C | Instil Bio, Inc. | 2.22 | |
GNTA | B | Genenta Science S.p.A. | 3.03 | |
ARGX | A | argenx SE | 0.06 |
Related Industries: Biotechnology Other
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EWK | A | iShares MSCI Belgium Capped Investable Market Index Fund | 6.71 | |
BBH | A | Market Vectors Biotech ETF | 5.11 | |
IWC | B | iShares Microcap ETF | 5.0 | |
MNTL | A | Tema Neuroscience and Mental Health ETF | 4.24 | |
CANC | B | Tema Oncology ETF | 3.56 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Recent Comments
- TraderMike on EOW Scans / Signals
- CrootsterOZ on EOW Scans / Signals
- TraderMike on Filter short-term up stocks
- CooperativeAlligator187 on Filter short-term up stocks
- TraderMike on Bollinger Band Squeeze
From the Blog
Featured Articles